Trial intelligence / Profile preview

Deferiprone added to idebenone for cardiac hypertrophy and function in Friedreich's ataxia

2007-004001-96Phase 4Active

Sponsor
Sant Joan de Déu Hospital
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of deferiprone and idebenone in Friedreich ataxia (FA) (2 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoint: Exclusion criteria occurrence during the trial. Started Mar 2010; status: active.

02

Drugs

deferiproneidebenone
03

Conditions

Friedreich ataxia (FA)

Beyond the preview

Go deeper on 2007-004001-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004001-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call